Development and Fabrication of Emodin-Loaded Patches Using Geraniol as a Penetration Enhancer for Transdermal...

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Biomedical Engineering

Background:

• Diabetes mellitus requires improved therapeutic strategies for better patient outcomes.
• Transdermal drug delivery systems offer a noninvasive route for medication administration, potentially enhancing patient adherence.
• Emodin, a natural compound, has shown potential in diabetes management, but its oral administration faces challenges.

Purpose of the Study:

• To formulate and optimize a transdermal patch containing emodin for diabetes treatment.
• To evaluate the physicochemical properties and drug release kinetics of the developed emodin transdermal patch.
• To explore the potential of emodin transdermal patches as a viable alternative to conventional oral therapies.

Main Methods:

• A full factorial experimental design was utilized to optimize patch composition, varying concentrations of hydroxypropyl methylcellulose K15 and geraniol.
• Fourier-transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) were employed to assess drug-excipient compatibility and thermal properties.
• In vitro drug release studies were conducted to characterize the release profile of emodin from the transdermal patches.

Main Results:

• The optimization study identified ideal concentrations of hydroxypropyl methylcellulose K15 and geraniol for the transdermal patch formulation.
• FTIR and DSC analyses confirmed the chemical compatibility of emodin with the chosen excipients and indicated favorable thermal characteristics.
• The transdermal patch exhibited a controlled release profile of emodin, suggesting sustained drug delivery.

Conclusions:

• The developed emodin-loaded transdermal patch represents a promising noninvasive approach for diabetes management.
• The optimized formulation possesses suitable physicochemical properties and drug release characteristics for potential therapeutic application.
• Transdermal delivery of emodin may overcome limitations associated with oral administration, improving treatment efficacy and patient compliance.